Kabra Drugs share news, announcements and annual reports
BSE: 524322Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹15.72.
30 Oct: open ₹15.99, high ₹16.49, low ₹15.67
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹39 Cr3,225th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 5.11
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.31
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 28.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 28.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.01
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 59,920
Kabra Drugs share news and announcements
558 announcements, routine notices left out, newest first. Page 7 of 12.
Nov 2020
4 Nov · Board meeting
Meeting on 13 Nov 2020: quarterly results
Oct 2020
29 Oct · Regulation 40(9)
19 Oct · Shareholding for the Period Ended September 30, 2020
Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click ....13 Oct · Compliance Certificate Under Regulation 7(3) Of The SEBI (LODR), Regulations 2015
13 Oct · Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 03 Oct · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Sep 2020
30 Sep · Meeting
7 Sep · Board meeting
Meeting on 15 Sep 2020: quarterly results7 Sep · Meeting
Aug 2020
27 Aug · Board meeting
Meeting on 2 Sep 2020
Jul 2020
22 Jul · Shareholding for the Period Ended June 30, 2020
Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click ....21 Jul · Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 09 Jul · Mr. B.V. Anatha Kumar Is Authorised To Look For New Premises For Corporate Office At Bangalore And Marketing Office At Chennai. .
3 Jul · Board meeting
Meeting on 9 Jul 2020
Jun 2020
23 Jun · Board meeting
Meeting on 30 Jun 2020: audited results11 Jun · Announcement under Regulation 30 (LODR)-Change in RTA
May 2020
29 May · Regulation 40(10)
7 May · Shareholding for the Period Ended March 31, 2020
Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click ....6 May · Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Mar 2020
Feb 2020
24 Feb · Board meeting
Meeting on 2 Mar 202012 Feb · Board meeting
Meeting on 19 Feb 2020
Jan 2020
31 Jan · Board meeting
Meeting on 5 Feb 202029 Jan · Submission Of Information To The Exchange Pursuant To Regulation 30 Of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015 ('SEBI (LODR) Regulations, 2015')
22 Jan · Board meeting
Meeting on 29 Jan 202021 Jan · Board meeting
Meeting on 8 Feb 2020: quarterly results